We demonstrate that PGRMC1 mediates progression of breast cancer cells potentially by altering cholesterol and lipid metabolism and activating key drivers of tumor progression in breast cancer, namely ERα expression and activation, as well as EGFR signaling. The gene discussed is EGFR; the disease is neoplasm.